Related Experiment Video
Updated: Jun 21, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
469
[Update on medullary thyroid carcinoma-What is relevant for surgeons?]
Kerstin Lorenz1, Andreas Machens2, Henning Dralle3
1Klinik für Viszerale, Gefäß- und Endokrine Chirurgie, Universitätsmedizin Halle, Ernst-Grube-Str. 40, 06120, Halle/Saale, Deutschland. kerstin.lorenz@uk-halle.de.
Chirurgie (Heidelberg, Germany)
|May 19, 2025
Summary
This article reviews surgical strategies for medullary thyroid carcinoma (MTC), focusing on risk factors, resection techniques, and prophylactic thyroidectomy for hereditary cases. It aligns with updated national guidelines for optimal patient care.
Area of Science:
- Endocrinology
- Surgical Oncology
- Genetics
Context:
- Medullary thyroid carcinoma (MTC) presents complex diagnostic and surgical challenges.
- Evolving research necessitates updated clinical guidelines and treatment strategies.
- Understanding sporadic and hereditary MTC subtypes is crucial for tailored management.
Purpose:
- To provide an overview of surgically relevant diagnostic and operative aspects of MTC.
- To discuss current trends from recent studies and their impact on national S3 guidelines.
- To outline individualized treatment options based on risk stratification and surgical approaches.
Summary:
- The article details diagnostic criteria, operative strategies, and risk factor assessment for MTC management.
- It covers standard procedures, intraoperative decision-making, and the characteristics of both sporadic and hereditary MTC.
- The concept of prophylactic thyroidectomy in hereditary MTC is explored in depth.
Impact:
- Facilitates informed clinical decision-making for MTC patients.
- Aims to standardize and improve surgical outcomes for medullary thyroid carcinoma.
- Contributes to the adaptation of national guidelines for MTC treatment.
Related Concept Videos
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...